Concepedia

Alexander P. Boardman

AP

Statistics

Publications

7

Citations

215

H-Index

7

Active since

2020

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Hospital Universitario Ramón y Cajal

Sheba Medical Center

University of Pennsylvania

Alexander P. Boardman is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, immunotherapy, and cancer immunotherapy.

ORCID

Publications per year

2020–2025

7

Publications

7

A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation

Matthew S. Davids, Haesook T. Kim, Caitlin Costello et al. · Blood · 2020 · 98 citations · Full text

, , +16

IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model

Brandon D. Ng, Adhithi Rajagopalan, Anastasia I. Kousa et al. · Blood · 2024 · 29 citations · Full text

, , +13

CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas

G. Cederquist, Javin Schefflein, Sean M. Devlin et al. · Blood Advances · 2024 · 27 citations · Full text

, , +11

Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell Lymphoma

Harper Hubbeling, Doris Leithner, Emily A. Silverman et al. · Clinical Cancer Research · 2024 · 20 citations · Full text

, , +17

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma

Pallawi Torka, Tatyana Feldman, Kerry J. Savage et al. · Journal of Clinical Oncology · 2024 · 17 citations · Full text

, , +14

1–5 of 7